See also this year's filing and all EDGAR filings for this company.
PDF Report 0000875622_2019_Biospecifics_Technologies_CORP.pdf
Logs
| warning | The EntityCommonStockSharesOutstanding does not exist | industry.us_generic | {} |
| warning | Missing logo | subcommand.report | {} |
Graph
Absolute values for 0000875622, Biospecifics Technologies CORP
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 98,233,962 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 444,478 |
| 2 | PropertyPlantAndEquipmentNet | 0 |
| 3 | remainder_Assets | 1,413,602 |
| 4 | LiabilitiesCurrent | 2,503,522 |
| 5 | LiabilitiesNoncurrent | 0 |
| 6 | remainder_Liabilities | 0 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 8,808,614 |
| 9 | ResearchAndDevelopmentExpense | 622,837 |
| 10 | remainder_Expenses | 4,956,042 |
| 11 | remainder_Revenues | 33,877,499 |
| 12 | remainder_NetIncome | 4,953,383 |
| 13 | remainder_ComprehensiveNetIncome | 0 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 100,092,042 |
| 1 | Liabilities | 2,503,522 |
| 2 | Expenses | 14,387,493 |
| 3 | Revenues | 33,877,499 |
| 4 | StockholdersEquity | 97,588,520 |
| 5 | NetIncome | 24,443,389 |
| 6 | ComprehensiveNetIncome | 24,443,389 |
| 7 | BaseVar | 77,906,970 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | 4.62 |
| 9 | EconomicCapitalRatio | 4.88 |
Edgar->Model Mapping
Feature Distribution
Change over Time
